The Acceptability and Feasibility of an Alternative to Routine Follow-up Visit After Medical Abortion in Vietnam
The Acceptability and Feasibility of an Alternative to a Routine Follow-up Visit After Medical Abortion in Vietnam
This trial will compare the efficacy and acceptability of post-medical abortion follow-up by assigning women to either 1) alternative follow-up via routine semi-quantitative pregnancy test and a self-administered follow-up questionnaire, or 2) the standard of care: a routine follow-up visit including a bimanual exam and vaginal ultrasound.
The goal of the study is to provide answers to the following questions:
- Is a follow-up protocol that employs a self-administered questionnaire and at home use of a semi-quantitative pregnancy test effective at identifying women with ongoing pregnancies?
- Is an innovative follow-up protocol more acceptable to women and providers than the current standard of care?
- Is an innovative follow-up protocol feasible to implement in abortion services in Vietnam?
Descripción general del estudio
Tipo de estudio
Inscripción (Anticipado)
Fase
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Hanoi, Vietnam
- National Ob-Gyn Hospital
-
Hanoi, Vietnam
- Hanoi Ob-Gyn Hospital
-
Ho Chi Minh City, Vietnam
- HocMon District Hospital
-
Ho Chi Minh City, Vietnam
- Hung Vuong Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Reproductive age women seeking medical abortion services
- Intrauterine pregnancy less than or equal to 63 days gestation on the day of mifepristone administration
- Hold a working, personal phone number
- be willing and able to sign consent forms and agree to comply with study procedures
Exclusion Criteria:
- Pregnancy greater than 63 days gestation on the day of mifepristone administration
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Standard of care for post medical abortion follow-up
Standard of care includes a routine hospital visit two weeks after mifepristone administration.
At the hospital visit, the woman will undergo a bimanual and vaginal ultrasound examination.
In the event the woman fails to return for the follow-up visit, each hospital will follow their standard procedure for contacting women who fail to attend their follow-up visit, i.e. three efforts to contact the woman.
Form 2a will document the results of any clinical examinations, any additional medical abortion-related care given and the abortion outcome.
At the follow-up visit, women will also be asked about the acceptability of current medical abortion follow-up procedures and their future preferences.
|
|
|
Comparador activo: Alternative follow-up
At their first clinic visit, women will be asked to provide their phone number for contact purposes. Women will also be asked to complete a semi-quantitative pregnancy test in the clinic and the results of the test will be noted on a study form. After mifepristone administration, women will be provided with a second semi-quantitative pregnancy test and a self-administered checklist. Women will be instructed to complete the checklist and perform the pregnancy test at home on an assigned date two weeks after mifepristone administration. The checklist will indicate that if the woman answers "yes" to any of the questions, then she should return to the clinic for a follow-up visit. On the assigned date, women will also be contacted by phone by the clinic staff. Women will be asked to confirm whether they completed the pregnancy test and checklist and asked to report on the results of both tests. |
After mifepristone administration, women will be provided with a second semi-quantitative pregnancy test and a self-administered checklist.
Women will be instructed to complete the checklist and perform the pregnancy test at home on an assigned data two weeks after mifepristone administration.
On the assigned date, women will also be contacted by phone by the clinic staff.
Women will be asked to confirm whether they completed the pregnancy test and checklist and asked to report on the results of both tests.
Provider will review the women's responses to the checklist and confirm whether, based on the woman's responses, she should return for a follow up visit.
During the follow-up phone call, women will also be asked about the satisfaction and acceptability of the alternative follow-up procedure.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Continued, ongoing pregnancy
Periodo de tiempo: 9 months
|
9 months
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
percentage of women who return for follow-up
Periodo de tiempo: 9 months
|
9 months
|
|
percentage of women receiving other treatment for ongoing pregnancy
Periodo de tiempo: 9 months
|
9 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Nguyen Thi Nhu Ngoc, MD, MSc, Center for Research and Consultancy in Reproductive Health
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 6.4
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .